BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16840191)

  • 1. Role of the molecular staging and response in the management of follicular lymphoma patients.
    Arcaini L; Colombo N; Bernasconi P; Calatroni S; Passamonti F; Orlandi E; Bonfichi M; Burcheri S; Porta MD; Rumi E; Montanari F; Algarotti A; Pascutto C; Lazzarino M
    Leuk Lymphoma; 2006 Jun; 47(6):1018-22. PubMed ID: 16840191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
    Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and clinical significance of bcl-2/IgH rearrangements in follicular lymphoma.
    Montoto S; López-Guillermo A; Colomer D; Esteve J; Bosch F; Ferrer A; Villamor N; Moreno C; Campo E; Montserrat E
    Leuk Lymphoma; 2003 Jan; 44(1):71-6. PubMed ID: 12691144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma.
    López-Guillermo A; Cabanillas F; McDonnell TI; McLaughlin P; Smith T; Pugh W; Hagemeister F; Rodríguez MA; Romaguera JE; Younes A; Sarris AH; Preti HA; Lee MS
    Blood; 1999 May; 93(9):3081-7. PubMed ID: 10216105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis between RQ-PCR and digital droplet PCR of BCL2/IGH gene rearrangement in the peripheral blood and bone marrow of early stage follicular lymphoma.
    Cavalli M; De Novi LA; Della Starza I; Cappelli LV; Nunes V; Pulsoni A; Del Giudice I; Guarini A; Foà R
    Br J Haematol; 2017 May; 177(4):588-596. PubMed ID: 28419517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report.
    Ha CS; Cabanillas F; Lee MS; Besa PC; McLaughlin P; Cox JD
    Clin Cancer Res; 1997 Feb; 3(2):215-9. PubMed ID: 9815675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A real-time (PCR) for a real life…? Quantitative evaluation of BCL2/IGH in follicular lymphoma and its implications for clinical practice.
    Janikova A; Mareckova A; Dvorakova D; Bortlicek Z; Tichy B; Navratil M; Kral Z; Pospisilova S; Mayer J
    Exp Hematol; 2012 Jul; 40(7):528-539.e4. PubMed ID: 22381682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage I/II follicular lymphoma: spread of bcl-2/IgH+ cells in blood and bone marrow from primary site of disease and possibility of clearance after involved field radiotherapy.
    Pulsoni A; Starza ID; Frattarelli N; Ghia E; Carlotti E; Cavalieri E; Matturro A; Tempera S; Rambaldi A; Foà R
    Br J Haematol; 2007 May; 137(3):216-20. PubMed ID: 17408460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma.
    Mahé B; Milpied N; Mellerin MP; Moreau P; Morineau N; Vigier M; Harousseau JL
    Bone Marrow Transplant; 2003 Mar; 31(6):467-73. PubMed ID: 12665842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative PCR detection of t(14;18) bcl-2/JH fusion sequences in follicular lymphoma patients: comparison of peripheral blood and bone marrow aspirate samples.
    Bowman A; Jones D; Medeiros LJ; Luthra R
    J Mol Diagn; 2004 Nov; 6(4):396-400. PubMed ID: 15507680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2/IgH expression in minimal bone marrow infiltration by follicular lymphoma cells.
    Che YQ; Liu P; Wang Y; Zhang CG; Han YL; Shen D; Zhang Y; Zheng CL; Qi J; Wang QT
    Mol Med Rep; 2012 Feb; 5(2):383-7. PubMed ID: 22052344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up.
    Apostolidis J; Gupta RK; Grenzelias D; Johnson PW; Pappa VI; Summers KE; Salam A; Adams K; Norton AJ; Amess JA; Matthews J; Bradburn M; Lister TA; Rohatiner AZ
    J Clin Oncol; 2000 Feb; 18(3):527-36. PubMed ID: 10653868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characteristics and prognostic significance of Bcl-2/IgH gene rearrangement in Serbian follicular lymphoma patients.
    Radojkovic M; Ristic S; Colovic M; Cemerikic-Martinovic V; Radojkovic D; Krtolica K
    Neoplasma; 2008; 55(5):421-7. PubMed ID: 18665753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Achieving Bcl-2/IgH negativity in peripheral blood/bone marrow after therapy implies better prognosis for patients with follicular lymphoma].
    Belada D; Smolej L; Stepánková P; Beránek M; Dvoráková D; Bukac J; Malý J
    Vnitr Lek; 2007 Oct; 53(10):1057-63. PubMed ID: 18072430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide-vincristine-prednisone plus interferon alpha 2b.
    Fernández-Ruiz E; Cabrerizo M; Ortega M; Blas C; Llamas P; Santos-Roncero M; Nieto S; Acevedo A; Pérez G; Nicolás C; Fernández-Rañada JM; Arranz R
    Clin Cancer Res; 2003 Jul; 9(7):2497-503. PubMed ID: 12855623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
    Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
    Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between histological subtype and type of bcl-2/IgH rearrangement in follicular lymphomas.
    Colleoni GW; Duarte LC; Kerbauy FR; Noguti MA; Da Silva ID; Otsuka AY; Alves AC; Silva MR
    Leuk Lymphoma; 2004 Feb; 45(2):331-8. PubMed ID: 15101720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of t(14;18) by PCR of IgH/BCL2 fusion gene in follicular lymphoma from archived cytological smears.
    Stoos-Veić T; Livun A; Ajduković R; Pejsa V; Jaksić O; Kusec R
    Coll Antropol; 2010 Jun; 34(2):425-9. PubMed ID: 20698113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fludarabine, cyclophosphamide and mitoxantrone for untreated follicular lymphoma: a report from the non-Hodgkin's lymphoma co-operative study group.
    Santini G; Chisesi T; Nati S; Porcellini A; Zoli V; Rizzoli V; Zupo S; Marino G; Rubagotti A; Polacco A; Spriano M; Vimercati R; Congiu AM; Ravetti JL; Aversa S; Candela M; Patti C
    Leuk Lymphoma; 2004 Jun; 45(6):1141-7. PubMed ID: 15359993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rearrangement of the 5' cluster region of the BCL2 gene in lymphoid neoplasm: a summary of nine cases.
    Yabumoto K; Akasaka T; Muramatsu M; Kadowaki N; Hayashi T; Ohno H; Fukuhara S; Okuma M
    Leukemia; 1996 Jun; 10(6):970-7. PubMed ID: 8667654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.